Patents by Inventor Hyeong Joon Lim

Hyeong Joon Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240352071
    Abstract: The present invention relates to a novel peptide compound or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 27, 2024
    Publication date: October 24, 2024
    Inventors: Yoo Seok Kim, Myoung Hwan Kim, Young In Kim, Taek Joo Lim, Hyeong Joon Lim, Jee Young Kim, Eun Young Park
  • Publication number: 20240228538
    Abstract: The present invention relates to a novel peptide compound or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 20, 2020
    Publication date: July 11, 2024
    Applicant: Eyebio Korea
    Inventors: Yoo Seok Kim, Myoung Hwan Kim, Young In Kim, Taek Joo Lim, Hyeong Joon Lim, Jee Young Kim, Eun Young Park
  • Patent number: 9290542
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating arteriosclerosis, comprising: a pharmaceutically effective amount of a protein comprising the amino acid sequence of SEQ ID NO: 1; and a pharmaceutically acceptable carrier. The composition of the present invention exhibits no toxicity in the liver or kidney and effectively reduces the formation of atherosclerotic plaques, thereby exhibiting efficacy in treating arteriosclerosis.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: March 22, 2016
    Assignee: EYEGENE, INC.
    Inventors: Yang Je Cho, Jin Wook Jang, Hyeong Joon Lim
  • Patent number: 9101581
    Abstract: A method for treating a vascular-related disease in a subject in need thereof, includes administering to the subject a peptide having a sequence Xaa-Gly-Asp. The peptide may have a sequence of SEQ ID NOS: 1, 2, 4, 6 to 10. The vascular-related disease may be edema and/or ischemia caused by blood leakage of blood vessel walls, damages of blood vessels or abnormal angiogenesis.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: August 11, 2015
    Assignee: EYEGENE INC.
    Inventors: Doo-Sik Kim, Yang-Je Cho, Won-Il Yoo, Oh-Woong Kwon, Jin-Wook Jang, Hyeong-Joon Lim, Soo-Mee Kwon
  • Publication number: 20150038405
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating arteriosclerosis, comprising: a pharmaceutically effective amount of a protein comprising the amino acid sequence of SEQ ID NO: 1; and a pharmaceutically acceptable carrier. The composition of the present invention exhibits no toxicity in the liver or kidney and effectively reduces the formation of atherosclerotic plaques, thereby exhibiting efficacy in treating arteriosclerosis.
    Type: Application
    Filed: March 11, 2013
    Publication date: February 5, 2015
    Inventors: Yang Je Cho, Jin Wook Jang, Hyeong Joon Lim
  • Publication number: 20140105868
    Abstract: A method for treating a vascular-related disease in a subject in need thereof, includes administering to the subject a peptide having a sequence Xaa-Gly-Asp. The peptide may have a sequence of SEQ ID NOS: 1, 2, 4, 6 to 10. The vascular-related disease may be edema and/or ischemia caused by blood leakage of blood vessel walls, damages of blood vessels or abnormal angiogenesis.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 17, 2014
    Applicant: EYEGENE, INC.
    Inventors: Doo-Sik KIM, Yang-Je CHO, Won-Il YOO, Oh-Woong KWON, Jin-Wook JANG, Hyeong-Joon LIM, Soo-Mee KWON
  • Patent number: 8372811
    Abstract: Disclosed is a composition for treating retinopathy comprising thrombin derived peptide as an effective component.
    Type: Grant
    Filed: September 21, 2007
    Date of Patent: February 12, 2013
    Assignee: Eyegene, Inc.
    Inventors: Jin Wook Jang, Hyeong Joon Lim, Yang Je Cho, Won Il Yoo, Doo Sik Kim, Oh Woong Kwon, Kyoung Chul Ko, Kyung Sul Kim
  • Publication number: 20100297100
    Abstract: Disclosed is a composition for treating retinopathy comprising thrombin derived peptide as an effective component.
    Type: Application
    Filed: September 21, 2007
    Publication date: November 25, 2010
    Applicant: Eyegene, Inc.
    Inventors: Jin-Wook Jang, Hyeong-Joon Lim, Yang-Je Cho, Won-Il Yoo, Doo-Sik Kim, Oh-Woong Kwon, Kyoung-Chul Ko, Kyung-Sul Kim
  • Publication number: 20090220463
    Abstract: Disclosed is a composition for treating vascular diseases by acting on abnormal angiogenesis by means of secretion of angiopoietins.
    Type: Application
    Filed: January 19, 2007
    Publication date: September 3, 2009
    Inventors: Doo-Sik Kim, Yang-Je Cho, Won-Il Yoo, Oh-Woong Kwon, Jin-Wook Jang, Hyeong-Joon Lim, Soo-Mee Kwon
  • Patent number: RE48023
    Abstract: A method for treating a vascular-related disease in a subject in need thereof, includes administering to the subject a peptide having a sequence Xaa-Gly-Asp. The peptide may have a sequence of SEQ ID NOS: 1, 2, 4, 6 to 10. The vascular-related disease may be edema and/or ischemia caused by blood leakage of blood vessel walls, damages of blood vessels or abnormal angiogenesis.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: June 2, 2020
    Assignee: EYEGENE INC.
    Inventors: Doo-Sik Kim, Yang-Je Cho, Won-Il Yoo, Oh-Woong Kwon, Jin-Wook Jang, Hyeong-Joon Lim, Soo-Mee Kwon